Inner Reach

Inner Reach is a biotechnology company focused on overcoming the challenges of delivering therapeutics to the central nervous system (CNS). The company has developed a proprietary delivery platform that utilizes specialized micro-catheters and imaging guidance to provide precise, targeted access to the brain and spinal cord, bypassing the blood-brain barrier. This technology is designed to enable the delivery of a wide range of modalities, including large molecules, proteins, and gene therapies, for the treatment of neurodegenerative and other neurological diseases. By providing a reliable route for CNS administration, Inner Reach aims to unlock the potential of therapies that were previously limited by poor brain penetration. The company is headquartered in North Carolina and is led by experienced medical device and biotech entrepreneurs.